Harm Reduction Services

Launched by NYU LANGONE HEALTH · Mar 6, 2023

Keywords

ClinConnect Summary

This clinical trial, called Harm Reduction Services, is looking at a new approach to help Black and Latinx individuals who use drugs. The study aims to see if an integrated harm reduction intervention (IHRI) can encourage more people to use harm reduction services compared to the usual services provided. Harm reduction services are strategies and programs designed to minimize the negative effects of drug use, such as overdose and disease transmission.

To be eligible for this study, participants need to be at least 18 years old, speak either English or Spanish, and have misused opioids or other substances in the past month. They will be asked questions in an interview to confirm their drug use. People who have severe mental health issues, are currently in prison, or cannot provide informed consent will not be able to participate. Those who join the study can expect support and resources, with the hope that this new approach will improve their access to services that can help them reduce risks associated with drug use.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • at least 18 years of age
• • self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria
• • English or Spanish speaking
• • able to provide informed consent.
• Exclusion Criteria:
• • inability to provide informed consent or participate in the study procedures as proposed in the consent
• • active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder)
• • an unwillingness to be randomized.
• • are prisoners